Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Dexmedetomidine as Synergistic Agent to Prolong a Subarachnoid Block Duration

NCT06662175 is registered in ClinicalTrials.gov with Lady Reading Hospital, Pakistan as lead sponsor.

NCT NCT06662175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06662175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Dexmedetomidine as Synergistic Agent to Prolong a Subarachnoid Block Duration
Lead sponsor
Lady Reading Hospital, Pakistan
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
November 30, 2024
Completion date
September 30, 2025
Enrollment
166 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, hyperbaric bupivacaine, subarachnoid anesthesia